Rejuvel Bio-Sciences, Inc./ US7594081074 /
13.06.2024 19:45:42 | Diff. 0.0000 | Volumen | Geld- | Brief- | Tageshoch | Tagestief |
---|---|---|---|---|---|---|
0.0000USD | 0.00% | 8.01 Mio. Umsatz: 8.0080 |
-Geld Vol: - | -Brief Vol: - | 0.0000 | 0.0000 |
GlobeNewswire
14:03
ElmediX Plans Series A Round Based on Strong Signals in a Clinical Study for Pancreatic Cancer Patie...
GlobeNewswire
14:00
Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress
GlobeNewswire
14:00
BIO-key Introduces Passkey:YOU, a Phish-resistant, Phoneless and Tokenless Biometric FIDO Passkey Au...
GlobeNewswire
14:00
Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of ...
GlobeNewswire
14:00
Spectrum Group International Announces Extension of Election Deadline for Proposed Cash Election Mer...
GlobeNewswire
14:00
Summit Nanotech and Zelandez Collaborate to Accelerate Modular Lithium Carbonation Project in South ...
GlobeNewswire
14:00
LiveOne (Nasdaq: LVO) Announces 244th Edition of LiveOne Presents as Streaming Partner for “The Game...
GlobeNewswire
14:00
ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with Iadademstat Plus Gilteritini...
GlobeNewswire
14:00
Findings on the Burdens of Diabetic Peripheral Neuropathic Pain (DPNP) Among Three Lexicon-Sponsored...
GlobeNewswire
13:50
Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American...
- Erste Seite
- Zurück
- 1
- 2
- 3
- 4
- Weiter
- Letzte Seite